自主神经功能障碍与帕金森病疾病进展及生存的关联
该回顾性研究基于100例尸检确诊的帕金森病患者,发现85例出现自主神经功能障碍,且其出现时间较早与疾病里程碑更快达成及生存期缩短独立相关。诊断时年龄较大和左旋多巴反应较差也与生存期缩短相关。
要点
- 自主神经功能障碍出现越早,帕金森病疾病进展越快、生存期越短。
- 诊断时年龄较大和左旋多巴反应较差是生存期缩短的其他独立因素。
- 自主神经功能障碍与α-突触核蛋白病理分期无关。
核心结论
- 较早出现自主神经功能障碍与帕金森病患者更快的疾病里程碑进展和更短的生存期相关。
研究设计与样本
- 回顾性队列研究,纳入2006年1月1日至2016年6月3日伦敦Queen Square脑库中100例尸检确诊的帕金森病患者。
主要发现
- 诊断时年龄较大和左旋多巴反应较差与更短生存期相关。
关键数值与推荐
- 自主神经功能障碍定义为自主神经功能测试提示自主神经衰竭,或存在以下症状中至少2项:泌尿系统症状、便秘、上消化道功能障碍、体位性低血压、出汗异常或勃起功能障碍。
临床怎么用
- 对帕金森病患者应关注自主神经功能障碍的出现时间,其较早出现提示疾病进展可能更快、生存期更短。
局限性
- 回顾性研究设计,样本来自单中心脑库,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Evidence suggests that development of autonomic dysfunction (AutD) may negatively affect disease course and survival in patients with synucleinopathies. However, the few available studies on Parkinson disease (PD) have conflicting results, comprise a small number of patients, have short follow-up periods, and lack pathologic confirmation of the diagnosis. OBJECTIVE: To examine the association of time of onset of AutD with disease progression and survival in PD. DESIGN, SETTING, AND PARTICIPANTS: This retrospective review of clinical data from 100 consecutive patients with an autopsy-confirmed diagnosis of PD from the archives of the Queen Square Brain Bank in London, United Kingdom, from January 1, 2006, to June 3, 2016, included patients with PD regularly seen by hospital specialists (neurologists or geriatricians) in the United Kingdom throughout their disease until death. Patients with dementia before or within 1 year after onset of motor symptoms, monogenic forms of PD, comorbidities that affect autonomic function, a coexisting neuropathologic diagnosis, or insufficient clinical information were excluded. MAIN OUTCOMES AND MEASURES: Survival and time from diagnosis to specific disease milestones were calculated to assess disease progression. Autonomic dysfunction was defined as autonomic failure at autonomic function testing or 2 of the following symptoms: urinary symptoms, constipation, upper gastrointestinal tract dysfunction, orthostatic hypotension, sweating abnormalities, or erectile dysfunction. Multivariable Cox proportional hazards regression models on the risk of a disease milestone and death were used. RESULTS: A total of 100 patients (60 [60.0%] male; mean [SD] age at diagnosis, 63.9 [10.3] years; mean [SD] disease duration, 14.6 [7.7] years) were studied. Autonomic dysfunction developed in 85 patients (mean [SD] time from diagnosis, 6.7 [7.7] years) and was associated with older age at diagnosis, male sex, poor initial levodopa treatment response, and postural instability and gait difficulty motor PD subtype in linear regression analysis, but staging of α-synuclein pathologic changes was unrelated. Earlier AutD increased the risk of reaching the first milestone (hazard ratio, 0.86; 95% CI, 0.83-0.89; P < .001) and shortened survival (hazard ratio, 0.92; 95% CI, 0.88-0.96; P < .001). Older age at diagnosis and poorer levodopa treatment response were the other factors associated with shorter survival in adjusted multivariate analysis. CONCLUSIONS AND RELEVANCE: Earlier AutD is associated with a more rapid development of disease milestones and shorter survival in patients with PD.
引用
- De Pablo-Fernandez E, Tur C, Revesz T, et al. Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease. JAMA Neurol. 2017. PMID: 28655059. doi:10.1001/jamaneurol.2017.1125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。